Posted Sep. 13, 2013 at 6:05 p.m.

Premium Lock 'Breakthrough' designation granted for leukemia therapy from GSK, partner Genmab

Published: 2013-09-13 18:05:47
Updated: 2013-09-13 18:05:47

Cancer research  Cancer research

Designation as a "breakthrough therapy" should speed up the FDA's evaluation of Arzerra in combination with another drug, to treat CLL, the most common form of leukemia in adults....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders